{"version":"1.0","type":"link","title":"15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study.","author_name":"Lai B 외","author_url":"https://prs-insight.online/author/Lai%20B","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/163580","thumbnail_width":1200,"thumbnail_height":630}